Mercedes-Benz Financial Statements From 2010 to 2024
| MBG Stock | EUR 52.68 0.23 0.44% |
Check Mercedes-Benz Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mercedes-Benz Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mercedes-Benz financial statements analysis is a perfect complement when working with Mercedes-Benz Group Valuation or Volatility modules.
Mercedes-Benz |
Mercedes Benz Group AG Company Return On Asset Analysis
Mercedes-Benz Group's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mercedes-Benz Group Return On Asset | 0.0398 |
Most of Mercedes-Benz Group's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mercedes Benz Group AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Mercedes Benz Group AG has a Return On Asset of 0.0398. This is 100.45% lower than that of the Healthcare sector and 100.17% lower than that of the Biotechnology industry. The return on asset for all Germany stocks is 128.43% lower than that of the firm.
Mercedes Benz Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mercedes-Benz Group's current stock value. Our valuation model uses many indicators to compare Mercedes-Benz Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mercedes-Benz Group competition to find correlations between indicators driving Mercedes-Benz Group's intrinsic value. More Info.Mercedes Benz Group AG is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.24 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Mercedes Benz Group AG is roughly 4.21 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mercedes-Benz Group's earnings, one of the primary drivers of an investment's value.About Mercedes-Benz Group Financial Statements
Mercedes-Benz Group stakeholders use historical fundamental indicators, such as Mercedes-Benz Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mercedes-Benz Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mercedes-Benz Group's assets and liabilities are reflected in the revenues and expenses on Mercedes-Benz Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mercedes Benz Group AG. Please read more on our technical analysis and fundamental analysis pages.
Marinomed Biotech AG, a biopharmaceutical company, develops products for respiratory and ophthalmological diseases in Austria, other European countries, and internationally. Marinomed Biotech AG was incorporated in 2006 and is headquartered in Korneuburg, Austria. MARINOMED BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 41 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Mercedes-Benz Stock
Mercedes-Benz Group financial ratios help investors to determine whether Mercedes-Benz Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mercedes-Benz with respect to the benefits of owning Mercedes-Benz Group security.